Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23447001 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Phase 1b Multicenter Study of Carfilzomib With Lenalidomide and Dexamethasone in Relapsed Multiple Myeloma
Condition: Relapsed Multiple Myeloma
Intervention: Drug: Carfilzomib with Lenalidomide and Dexamethasone

Indicates status has not been verified in more than two years